Amplify Weight Loss Drug & Treatment ETF

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.

Index-Tracked

VettaFi Weight Loss Drug & Treat TR USD

Index-TrackedVettaFi Weight Loss Drug & Treat TR USD

What's in this fund

Sectors

As of December 15, 2025

Healthcare100.00%

Top 10 Holdings (75.10% of total assets)

As of December 15, 2025

NameSymbol% Assets

Eli LillyLLY16.12%

Novo NordiskNVO10.66%

RegeneronREGN8.11%

Chugai Pharmaceutical Co Ltd4519 (XTKS)7.41%

AmgenAMGN7.06%

Roche Holding AGROG (XSWX)5.51%

THNR Key Statistics

AUM

2.78M

AUM2.78M

Price-Earnings ratio

20.37

Price-Earnings ratio20.37

30-Day yield

1.40

30-Day yield1.40

Average volume

1.52K

Average volume1.52K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$26.27

52 Week high$26.27

52 Week low

$18.56

52 Week low$18.56

Expense ratio

0.59

Expense ratio0.59

View Prospectus and Reports

Stock Snapshot

The current Amplify Weight Loss Drug & Treatment ETF(THNR) stock price is $25.00, with a market capitalization of 2.75M. The stock trades at a price-to-earnings (P/E) ratio of 20.37 and offers a dividend yield of 1.8%.

During the trading day, Amplify Weight Loss Drug & Treatment ETF(THNR) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.52K.

The stock's 52-week range extends from a low of $18.56 to a high of $26.27.